Christopher J. Matheson

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines

Christopher R. Coxon, Elizabeth Anscombe, Suzannah J. Harnor et al. · Journal of Medicinal Chemistry · 2016 · 119 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Allosteric Inhibitors of the Eya2 Phosphatase Are Selective and Inhibit Eya2-mediated Cell Migration

Aaron Krueger, David Drasin, Wendy Lea et al. · Journal of Biological Chemistry · 2014 · 57 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells

Christopher J. Matheson, Sujatha Venkataraman, Vladimir Amani et al. · ACS Chemical Biology · 2016 · 57 citations

Medicine, Oncology, Pharmacology +15

Trifluoroacetic Acid in 2,2,2‐Trifluoroethanol Facilitates S_NAr Reactions of Heterocycles with Arylamines

Benoît Carbain, Christopher R. Coxon, Honorine Lebraud et al. · Chemistry - A European Journal · 2014 · 39 citations

Natural Sciences, Chemistry, Medicinal Chemistry +7

Molecular docking of substituted pteridinones and pyrimidines to the ATP-binding site of the N-terminal domain of RSK2 and associated MM/GBSA and molecular field datasets

Kimberly A. Casalvieri, Christopher J. Matheson, Donald S. Backos et al. · Data in Brief · 2020 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17